FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Track all the latest updates and news of Supriya Lifescience IPO.
April 5, 2024 10:30:00 AM
Contineum Therapeutics has lowered its IPO expectations as the Johnson & Johnson-partnered biotech prepares to make the jump to the public markets this morning Friday, April 5. The San Diego-based ...
Published by : FierceBiotechMarch 28, 2024 10:40:00 AM
Boundless Bio is bringing in $100 million from its IPO as the precision oncology company becomes the latest biotech to go public in 2024. The company has priced its 6.25 million shares at $16 ...
Published by : FierceBiotechApril 24, 2024 5:03:00 AM
"After holding IPO pitches recently with investment bankers, Sai Life Sciences has engaged Kotak Mahindra Capital, Jefferies, IIFL Capital and Morgan Stanley. It is likely to be a combination of ...
Published by : moneycontrol.comApril 2, 2024 1:34:00 PM
It's the latest venture capital-backed company to pursue its Wall Street dreams as the IPO market thaws. Should the company�s IPO be successful, it would join San Francisco-based social media ...
Published by : The Business JournalsApril 2, 2024 1:15:00 PM
Private equity firm Silver Lake is acquiring all outstanding shares, stockholders will receive $27.50 per share, and will value the owner of WME at $13 billion. By Erik Hayden Executive Editor ...
Published by : The Hollywood ReporterApril 10, 2024 11:30:00 AM
The Japanese owner of 7-Eleven, Seven & i Holdings, is considering listing its superstore business as part of efforts to focus on its convenience-store segment. The company, which also owns other ...
Published by : Wall Street JournalApril 3, 2024 3:29:00 AM
The financial loss comes days after reports of Bithumb facing potential internal issues that led to the delay of its planned IPO. Bitkub targets to go public on the Stock Exchange of Thailand in ...
Published by : CoinTelegraphApril 11, 2024 8:36:00 AM
The Reddit IPO will arguably go down as one of the most anticipated initial public offerings (IPOs) of 2024, and it did not disappoint. On Wednesday, March 20, the social media company priced its ...
Published by : KiplingerMarch 27, 2024 4:04:00 PM
However, IPO volumes were flat on the same period last year and less than half the levels seen in early 2022, with $22.4 billion raised in the first quarter so far. With interest rate cuts ...
Published by : ReutersApril 5, 2024 3:30:00 AM
While the cruise line has not disclosed the number of shares that will be offered or their pricing, Barron's estimated Viking's IPO could be valued at over $10 billion. Cruise stocks have started ...
Published by : InvestopediaThe IPO Shares of Supriya Lifescience Limited IPO are proposed to list on Tuesday, December 28, 2021 at BSE, NSE. The public issue of Supriya Lifescience IPO was opened on Dec 16, 2021 and closed for subscription on Dec 20, 2021. Supriya Lifescience IPO Listing Date and Information:
Listing Date | Tuesday, December 28, 2021 |
BSE Script Code | 543434 |
NSE Symbol | SUPRIYA |
Listing In | B Group of Securities |
ISIN | INE07RO01027 |
Issue Price | ₹274 Per Equity Share |
Face Value | ₹2 Per Equity Share |
The allotment status of Supriya Lifescience Limited IPO is now available online. The public issue of Supriya Lifescience IPO was open on Dec 16, 2021 and closed for subscription on Dec 20, 2021. The equity shares of the company to be list at BSE, NSE.
Supriya Lifescience Limited is entering in the capital market with an IPO of [.] Equity Shares of Rs 2 aggregating up to Rs 700.00 Crore. The price for the issue has been set at Rs - Rs Per Equity Share.
Supriya Lifescience is engaged in the manufacturing of Active pharmaceutical ingredients (APIs). As of March 31, 2021, the company produces 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic. The company has been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India between Fiscal 2017 and 2021. The company is also one of the largest exporters of Salbutamol Sulphate from India in FY 2021 in terms of volume.
The issue opens on Dec 16, 2021 and closes for subscription on Dec 20, 2021. The equity shares of the company to be list at BSE, NSE.
The issue of Supriya Lifescience Limited opens on Dec 16, 2021 and closes for subscription on Dec 20, 2021. The equity shares of the company to be list at BSE, NSE. The price for the issue has been set at Rs - Rs Per Equity Share.
The Supriya Lifescience IPO is proposed to open on December 16, 2021. The IPO application ends on December 20, 2021.
Retail investors can apply in the retail or non-institutional investor category from December 16, 2021 to December 20, 2021. The Supriya Lifescience IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Supriya Lifescience IPO will open for subscription on December 16, 2021. The public issue will close on December 20, 2021.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|